IntegraGen SA has entered into global distribution agreement with Twist Bioscience Corp. The agreement includes distribution rights for SIRIUS, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists transforming raw data obtained via high-throughput sequencing into a molecular report for translational and clinical research use. The agreement enables Twist Bioscience to distribute SIRIUS and MERCURY genomic data analysis tools.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.03 USD | +1.55% | +8.76% | -13.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.10% | 1.82B | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- IntegraGen SA Announces Global Distribution Agreement with Twist Bioscience Corp